They revealed the mutation of ARID1A, which codes BAF250a protein, in about half of ovarian clear cell carcinomas (23,24), and PBRM1, which codes BAF180, in approximately 40% of renal cell carcinomas (25). This evidence concerns the gene ARID1A and ovarian clear cell cancer.